Hematology TimesPLK1 inhibitor receives orphan designation for AMLAugust 31, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesEC approves product for high-risk AMLAugust 28, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA grants fast track designation to CX-01 for AMLAugust 28, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesRegimen appears effective in elderly, unfit MDS/AMLAugust 25, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsFDA grants orphan designation to DHODH inhibitor for AMLAugust 21, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesRole of SES in childhood cancer survival disparitiesAugust 21, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesInhibitor receives orphan designation for AMLAugust 21, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsFDA puts partial hold on trial of vascular agent for AML, MDSAugust 20, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesAccess to care drives disparity between urban, rural cancer patientsAugust 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesPartial hold placed on trial of drug for AML, MDSAugust 18, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesDrug under priority review for BPDCNAugust 15, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAuto-HSCT linked to higher AML, MDS riskAugust 14, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLMyelodysplastic Syndrome
Hematology TimesFamilial risk of myeloid malignanciesAugust 13, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Hematology NewsAutotransplant is linked to higher AML, MDS riskAugust 10, 2018AMLAggressive LymphomasMixed TopicsLymphoma & Plasma Cell Disorders
Hematology TimesIxazomib could improve treatment of AMLAugust 10, 2018Leukemia, Myelodysplasia, TransplantationAML
